[1]
Muhamad Sajjad Sadiq, Muhammad Atiq Ur Rehman Khan, Muhammad Adnan Khan, Adil Shabbir, and Feroza Zarin, “Effectiveness of SGLT2 inhibitor (Empagliflozin) in reduction of albuminuria in type 2 Diabetics”, PJBMR, vol. 1, no. 4, pp. 26–38, May 2024, doi: 10.61171/2av4gt96.